For the millions of adults over 60 who take a daily thyroid hormone pill—often started decades earlier—the question of whether treatment is still necessary rarely gets asked. A prospective trial now offers evidence that challenges the assumption of lifelong levothyroxine dependency in this age group, with implications for deprescribing efforts worldwide.
The open-label, single-group prospective study enrolled adults aged 60 and older who were established on levothyroxine therapy and assessed what proportion could successfully discontinue the medication while maintaining clinically acceptable thyroid function. The response letter to JAMA clarifies key methodological and clinical details of this work, particularly around how 'acceptable thyroid function' was defined post-discontinuation and which patient subgroups fared best after stopping treatment. The study's findings suggest a meaningful subset of older patients—likely those originally treated for subclinical hypothyroidism or borderline TSH elevations—may no longer require ongoing therapy.
This finding lands in a broader clinical conversation about overtreatment in aging populations. Levothyroxine is among the most prescribed medications globally, yet evidence has long suggested that subclinical hypothyroidism in older adults often does not warrant treatment—a point reinforced by the landmark TRUST trial, which found no symptomatic benefit from thyroid hormone therapy in this demographic. The current work extends that logic by demonstrating that discontinuation, not just withholding initiation, may be safe for a substantial share of older patients already on therapy. Key limitations include the open-label, single-arm design, which lacks a placebo comparator and cannot fully rule out regression to the mean as an explanation for maintained euthyroidism. Whether findings generalize to patients with autoimmune thyroiditis or those with originally higher TSH levels remains uncertain. Still, this represents a clinically meaningful contribution to deprescribing science—incremental but practically actionable for geriatric care teams.